137 related articles for article (PubMed ID: 37234320)
1. Estimation of salivary and serum CYFRA 21-1 levels in patients with oral squamous cell carcinoma.
Adusumilli P; Babburi S; Venigalla A; Benarji KA; Sai SK; Soujanya P
J Oral Maxillofac Pathol; 2023; 27(1):98-102. PubMed ID: 37234320
[TBL] [Abstract][Full Text] [Related]
2. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
4. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
5. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation.
Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU
Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
7. Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors.
Jeiroodi N; Aslani SM; Khademi B; Malekzadeh M; Jaafari-Ashkavandi Z
Iran J Otorhinolaryngol; 2017 Jul; 29(93):203-208. PubMed ID: 28819618
[TBL] [Abstract][Full Text] [Related]
8. Assessment of salivary levels of ErbB2 in oral squamous cell carcinoma.
Jayarajkumar S; Ramamoorthi R; Muniapillai S; Gopalakrishnan S; Jayaseelan VP
J Oral Maxillofac Pathol; 2023; 27(4):777. PubMed ID: 38304523
[TBL] [Abstract][Full Text] [Related]
9. A study to estimate the serum IgA and salivary IgA levels in patients with oral leukoplakia and oral squamous cell carcinoma.
Yadav P; Shetty V; Dave A; Chandolia B; Mathur A; Saluja P
J Oral Maxillofac Pathol; 2023; 27(2):275-281. PubMed ID: 37854900
[TBL] [Abstract][Full Text] [Related]
10. CYFRA 21-1 and MMP-9 as salivary biomarkers for the detection of oral squamous cell carcinoma: a systematic review of diagnostic test accuracy.
AlAli AM; Walsh T; Maranzano M
Int J Oral Maxillofac Surg; 2020 Aug; 49(8):973-983. PubMed ID: 32035907
[TBL] [Abstract][Full Text] [Related]
11. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of CYFRA 21-1 as a tumour marker in patients with oropharyngeal squamous cell carcinoma.
Rudhart SA; Gehrt F; Birk R; Schultz JD; Stankovic P; Georgiew R; Wilhelm T; Stuck BA; Hoch S
Eur Arch Otorhinolaryngol; 2020 Sep; 277(9):2561-2571. PubMed ID: 32285192
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
15. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
17. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
[TBL] [Abstract][Full Text] [Related]
18. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
19. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer.
Pujol JL; Grenier J; Daurès JP; Daver A; Pujol H; Michel FB
Cancer Res; 1993 Jan; 53(1):61-6. PubMed ID: 7677981
[TBL] [Abstract][Full Text] [Related]
20. Total sialic acid, total protein and total sugar levels in serum and saliva of oral squamous cell carcinoma patients: A case control study.
Dhakar N; Astekar M; Jain M; Saawarn S; Saawarn N
Dent Res J (Isfahan); 2013 May; 10(3):343-7. PubMed ID: 24019802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
